Tracxn's proprietary #taxonomy brings to you top #BusinessModels in Life Sciences rebrand.ly/1iif73g Get our free reports on #PracticeArea or #sector of your interest to your mailbox regularly https://rb.gy/cx2upn

1. TRACXN TOP BUSINESS MODELS REPORT
November 17, 2021
LIFE SCIENCES

2. Life Sciences - Top Business Models Report Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Contents
Life Sciences Funding - Overview 3
Top Funded Business Models 4
One pagers 9
Appendix 59
2

3. Life Sciences - Top Business Models Report Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Funding in last 1 year
3
Oncology $18.2B
Genomics $15.5B
Life Sciences Platforms and Tools $10.5B
Life Sciences Tech $8.2B
Neurology $5.1B
Immunology $4.2B
Y-o-Y Funding
Top Investors by Funding Rounds
Seed
Stage
Y Combinator
Illumina
SOSV
28
7
6
Early
Stage
Alexandria
Orbimed
RA Capital Management
34
33
32
Late
Stage
RA Capital Management
Orbimed
Fidelity Investments
21
19
16
Funding by Geography
Top Feeds by $ Funding
Top Funding Rounds
United States (67%)
China (11%)
United Kingdom (7%)
France (2%)
Germany (2%)
Denmark (2%)
Canada (2%)
Others (8%)
$ Funding # Rounds
Caris Life Sciences
(1996, United States)
$830M - Series D
AboGen
(2012, United States)
$700M - Series A
CMR Surgical
(2014, United Kingdom)
$600M - Series D
LEO Pharma
(1908, Denmark)
$537M - PE
ElevateBio
(2018, United States)
$525M - Series C
Neumora
(2020, United States)
$500M - Series A
Laronde
(2017, United States)
$440M - Series B
Pivot Bio
(2010, United States)
$430M - Series D
Insitro
(2018, United States)
$400M - Series C
XtalPi
(2014, United States)
$400M - Series D
Adagio
(2020, United States)
$336M - Series C
Medable
(2012, United States)
$304M - Series D

4. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (1/5)
4
Rank Business Model $ Funding # Rounds Top Funding Round Details
1<> 0 Drugs for Multiple Cancer Types $11.2B 292 Clover Biopha.. | $230M | Series C Link
2<> 0 Life Sciences Research Services $3.7B 113 Tessera Thera.. | $230M | Series B Link
3▲5 Neurological Disorder Drugs $2.0B 46 Neumora | $500M | Series A Link
4▼1 Gene Therapy Drugs $2.0B 53 Wugen | $172M | Series B Link
5▲2 Sequencing-based Genomic Precision Medicine $1.7B 32 Caris Life Sc.. | $830M | Series D Link
6▲52 Robot Assisted Surgery $1.5B 27 CMR Surgical | $600M | Series D Link
7▲4 Genomic Data Analysis Platforms $1.4B 16 Element Biosc.. | $276M | Series C Link
8▲18 Gene Editing Platforms $1.4B 25 Tessera Thera.. | $230M | Series B Link
9<> 0 Autoimmune Disorders Drugs $1.2B 26 Sonoma Biothe.. | $265M | Series B Link
10▲3 Neurodegenerative Disorders Drugs $1.1B 37 Sonoma Biothe.. | $265M | Series B Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

5. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (2/5)
5
Rank Business Model $ Funding # Rounds Top Funding Round Details
11▲5 Hematologic Cancer Drugs $1.0B 13 ElevateBio | $525M | Series C Link
12▼8 Pan-Cancer Drugs $1.0B 29 Hummingbird B.. | $125M | Series C Link
13▲81 Diversified $890M 20 NewAmsterdam .. | $196M | Series A Link
14▲14 Proteomics Research Services $852M 13 Somalogic | $212M | Series E Link
15▲224 Biopreservation Devices $812M 10 AboGen | $700M | Series A Link
16▲66 Agrigenomics $807M 23 Inari | $208M | Series D Link
17▲3 Genomic Sequence Analysis Softwares $773M 16 Element Biosc.. | $276M | Series C Link
18▼13 Cancer Diagnostic Tests $737M 14 Color | $167M | Series D Link
19▼4 Inflammatory Diseases Drugs $654M 19 Apollo Therap.. | $145M | Series A Link
20▼2 Diabetes Drugs $606M 21 Jaguar Gene T.. | $139M | Series B Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

6. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (3/5)
6
Rank Business Model $ Funding # Rounds Top Funding Round Details
21▲41 At-Home Preventive Genetic Test Kits $598M 10 Everly Wellness | $175M | Series D Link
22▲10 Synthetic Biology $563M 10 Pivot Bio | $430M | Series D Link
23▲22 COVID-19 Drugs $562M 12 Adagio | $336M | Series C Link
24▼18 DNA Liquid Biopsy Diagnostics $553M 15 Jiyinga Techn.. | $116M | Series C Link
25▼8 Nucleic Acid Sequencing Equipment $544M 12 Nanopore | $271M | Series H Link
26▼2 Genomic Sequencing Instruments $507M 13 Nanopore | $271M | Series H Link
27▲42 Ophthalmology Drugs $463M 33 Gyroscope | $148M | Series C Link
28▲106 Patient Recruitment Platforms for Clinical Trials $462M 9 Reify Health | $220M | Series C Link
29▼17 RNA Interference Platforms $448M 6 Siwei Biotech.. | $188M | Series B Link
30▲3 Genomics Research Services $444M 36 Caribou Biosc.. | $115M | Series C Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

7. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (4/5)
7
Rank Business Model $ Funding # Rounds Top Funding Round Details
31▼21 Retinal Disorders Drugs $439M 16 Vedere | $77.0M | Series A Link
32▲41 Decentralized Clinical Trial Management $418M 4 Medable | $304M | Series D Link
33▼2 Genomics Based Drug Development Software $404M 8 Insilico | $255M | Series C Link
34▲20 Metabolic Disorders Drugs $389M 28 VISEN Pharmac.. | $150M | Series B Link
35▲180 Life Sciences Research Instruments $368M 9 Esco | $200M | Series A Link
36▲16 Anti Bacterial Drugs $360M 20 Affinivax | $226M | Series C Link
37▲411 Molecular Modeling Solutions $358M 8 Cellarity | $123M | Series B Link
38▲76 Genome Engineering Services $358M 5 Artiva | $120M | Series B Link
39▲193 Metabolic Disorders Drugs $345M 8 Jaguar Gene T.. | $139M | Series B Link
40▲62 Lung Infection Drugs $334M 6 HilleVax | $135M | Series D Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

8. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Top Funded Business Models - last 1 year (5/5)
8
Rank Business Model $ Funding # Rounds Top Funding Round Details
41▲89 Nanoparticle Based Drug Delivery Systems $330M 12 Siwei Biotech.. | $188M | Series B Link
42▲119 Cancer Precision Medicine Diagnostic Tests $327M 12 ITM | $109M | Series D Link
43▲52 Neurological Pain Management Drugs $321M 13 Eliem Therap.. | $80.0M | Series C Link
44▼19 Congestive Heart Failure Treatment Devices $310M 15 Ancora Heart | $80.0M | Series D Link
45▼22 Drug Resistant Infections $301M 12 MicuRx Pharma.. | $107M | Series E Link
46▲171 Clinical Data Analysis Platforms $284M 10 iCarbonX | $151M | Series D Link
47▲116 Wound Healing Drugs $280M 11 QBiotics | $64.4M | Series C Link
48▲81 Genetic Engineering Technologies $280M 6 Senti Bioscie.. | $105M | Series B Link
49<> 0 Cardiac Diagnostic Devices $274M 12 Imperative Care | $260M | Series D Link
50▼20 Gene Delivery Platforms $269M 11 Cambridge Ep.. | $88.0M | Series D Link
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1 year.

9. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Clover Biopharma (2007, China)
$230M - Series C - Feb 2021
Umoja Biopharma (2019, United States)
$210M - Series B - Jun 2021
Pyxis Oncology (2018, United States)
$173M - Series B - Mar 2021
Vaccitech (2016, United Kingdom)
$168M - Series B - Mar 2021
Scorpion (2020, United States)
$162M - Series B - Jan 2021
Century Thera.. (2018, United States)
$160M - Series C - Mar 2021
IO Biotech (2014, Denmark)
$155M - Series B - Jan 2021
View all 292 Funding Rounds on Tracxn Platform
Drugs for Multiple Cancer Types
01
9
Back to index
Oncology (Guardant Health)
(# Cos: 4430 | $97.3B)
Drugs (BioNTech)
(# Cos: 2837 | $74.5B)
Diversified (Moderna)
(# Cos: 2251 | $59.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$11.2B (▲12.8%)
292(▲17.7%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
190
$59.2B
1598
363
2251
262
Moderna
(2010, United States, $2.8B)
BioNTech
(2008, Germany, $806M)
Kite Pharma
(2009, United States, $97.7M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

10. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Tessera Thera.. (2018, United States)
$230M - Series B - Jan 2021
Arbor Biotech.. (2016, United States)
$215M - Series B - Nov 2021
Immunai (2018, United States)
$215M - Series B - Oct 2021
Wugen (2018, United States)
$172M - Series B - Jul 2021
Mammoth (2017, United States)
$150M - Series D - Sep 2021
Vividion Ther.. (2016, United States)
$135M - Series C - Feb 2021
Modern Meadow (2011, United States)
$130M - Series C - Apr 2021
View all 113 Funding Rounds on Tracxn Platform
Life Sciences Research Services
02
10
Back to index
Life Sciences Platforms and Tools (Illumina)
(# Cos: 9736 | $52.1B)
Research Services (Human Longevity)
(# Cos: 5051 | $32.3B)
Diversified (Ginkgo Bioworks)
(# Cos: 3423 | $25.7B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$3.7B (▲19.6%)
113(▼33.9%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
307
$25.7B
1855
183
3423
164
Ginkgo Bioworks
(2009, United States, $796M)
Human Longevity
(2013, United States, $330M)
Indigo
(2013, United States, $1.1B)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

11. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Neumora (2020, United States)
$500M - Series A - Oct 2021
Jaguar Gene T.. (2019, United States)
$139M - Series B - Apr 2021
Neurelis (2007, United States)
$115M - Series D - Mar 2021
Edgewise Ther.. (2017, United States)
$95.0M - Series C - Dec 2020
Vigil (2020, United States)
$90.0M - Series B - Aug 2021
Flare Therape.. (2021, United States)
$82.0M - Series A - May 2021
Faze Medicines (2019, United States)
$81.0M - Series A - Dec 2020
View all 46 Funding Rounds on Tracxn Platform
Neurological Disorder Drugs
03
11
Back to index
Neurology (MindMaze)
(# Cos: 2511 | $30.2B)
Drugs (Biogen)
(# Cos: 1341 | $23.7B)
Diversified (Biohaven Pharmaceutical)
(# Cos: 325 | $6.6B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$2.0B (▲148%)
46(▲21.1%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
32
$6.6B
231
52
325
39
Biohaven Pharmaceutical
(2014, United States, $84.1M)
PureTech Health
(2001, United States, $107M)
Cerevance
(2015, United States, $106M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

12. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Gene Therapy Drugs
04
12
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$2.0B (▼20.9%)
53(▼13.1%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
54
$12.4B
352
79
524
65
Genomics (MyHeritage)
(# Cos: 7580 | $80.5B)
Applied Genomics (23andMe)
(# Cos: 4093 | $53.3B)
Clinical Genomics (Guardant Health)
(# Cos: 2181 | $39.4B)
Therapeutics (CRISPR Therapeutics)
(# Cos: 524 | $12.4B)
CRISPR Therapeutics
(2013, Switzerland, $127M)
Alnylam
(2002, United States, $17.0M)
AskBio
(2001, United States, $235M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Wugen (2018, United States)
$172M - Series B - Jul 2021
Gyroscope (2016, United Kingdom)
$148M - Series C - Mar 2021
Forge Biologics (2020, United States)
$120M - Series B - Apr 2021
Ring Therapeu.. (2018, United States)
$117M - Series B - Jul 2021
Neurogene (2001, United States)
$115M - Series B - Dec 2020
Sirnaomics (2007, United States)
$105M - Series E - Jul 2021
Dyno Therapeu.. (2018, United States)
$100M - Series A - May 2021
View all 53 Funding Rounds on Tracxn Platform

13. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Sequencing-based Genomic Precision
Medicine
05
13
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.7B (▲90.8%)
32(▼3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
33
$12.2B
214
50
397
34
Genomics (MyHeritage)
(# Cos: 7580 | $80.5B)
Applied Genomics (23andMe)
(# Cos: 4093 | $53.3B)
Clinical Genomics (Invitae)
(# Cos: 2181 | $39.4B)
Diagnostics (Adaptive Biotechnologies)
(# Cos: 1624 | $26.5B)
Sequencing-based (Guardant Health)
(# Cos: 1327 | $24.5B)
Precision Medicine (Bluebird Bio)
(# Cos: 397 | $12.2B)
Bluebird Bio
(1992, United States, $136M)
UniQure
(1998, Netherlands, $200M)
MiRagen
(2007, United States, $43.6M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Caris Life Sc.. (1996, United States)
$830M - Series D - May 2021
Deep Genomics (2015, Canada)
$180M - Series C - Jul 2021
SHINE Medical.. (2010, United States)
$150M - Series C - Jun 2021
Omega Therape.. (2016, United States)
$126M - Series C - Mar 2021
BerryOncology (2017, China)
$108M - Series B - Aug 2021
DTx Pharma (2017, United States)
$100M - Series B - Mar 2021
Bluestar Geno.. (2016, United States)
$70.0M - Series C - May 2021
View all 32 Funding Rounds on Tracxn Platform

14. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Robot Assisted Surgery
06
14
Back to index
Surgical Instruments (Intuitive)
(# Cos: 682 | $6.7B)
Robotic Surgery (CMR Surgical)
(# Cos: 177 | $4.4B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.5B (▲868%)
27(▲200%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
20
$4.4B
110
13
177
26
CMR Surgical
(2014, United Kingdom, $1.0B)
Intuitive
(1995, United States, $47.0M)
TransEnterix
(2006, United States, $96.2M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
CMR Surgical (2014, United Kingdom)
$600M - Series D - Jun 2021
Edge Medical Robotics (2017, China)
$200M - Series C - Nov 2021
eCential Robotics (2009, France)
$120M - Series C - Jan 2021
Memic Surgery (2013, Israel)
$96.0M - Series D - Apr 2021
Edge Medical Robotics (2017, China)
$92.6M - Series B - Jan 2021
PROCEPT BioRo.. (2009, United States)
$85.0M - Series G - Jun 2021
ColubrisMX (2017, United States)
$76.1M - Series C - Jun 2021
View all 27 Funding Rounds on Tracxn Platform

15. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Element Biosc.. (2017, United States)
$276M - Series C - Jun 2021
Insilico (2014, China)
$255M - Series C - Jun 2021
Benchling (2012, United States)
$200M - Series E - Apr 2021
iCarbonX (2015, China)
$151M - Series D - Apr 2021
Singlera Geno.. (2014, United States)
$150M - Series B - Dec 2020
Singlera Geno.. (2014, United States)
$150M - Series B - Dec 2020
BioAge Labs (2015, United States)
$90.0M - Series C - Dec 2020
View all 16 Funding Rounds on Tracxn Platform
Genomic Data Analysis Platforms
07
15
Back to index
Genomics (23andMe)
(# Cos: 7580 | $80.5B)
Genome Informatics (Quest Diagnostics)
(# Cos: 734 | $4.9B)
Integrative Bioinformatics Platforms
(Human Longevity)
(# Cos: 470 | $4.0B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.4B (▲93.6%)
16(▼15.8%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
39
$4.0B
166
6
470
16
Human Longevity
(2013, United States, $330M)
Quest Diagnostics
(1967, United States)
Benchling
(2012, United States, $350M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

16. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Gene Editing Platforms
08
16
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.4B (▲311%)
25(▲92.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
4
$2.4B
62
2
94
15
Genomics (23andMe)
(# Cos: 7580 | $80.5B)
Enabling Technologies (Nanopore)
(# Cos: 1688 | $16.1B)
Technology Platforms (Twist Bioscience)
(# Cos: 363 | $7.6B)
Gene Editing (eGenesis)
(# Cos: 94 | $2.4B)
eGenesis
(2015, United States, $265M)
Locus Biosciences
(2015, United States, $32.3M)
Scribe Therapeutics
(2018, United States, $120M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Tessera Thera.. (2018, United States)
$230M - Series B - Jan 2021
Prime Medicine (2019, United States)
$200M - Series B - Jul 2021
Graphite Bio (2020, United States)
$151M - Series B - Mar 2021
eGenesis (2015, United States)
$125M - Series C - Mar 2021
Scribe Therap.. (2018, United States)
$100M - Series B - Mar 2021
Locana (2016, United States)
$100M - Series B - Dec 2020
Remix Therape.. (2019, United States)
$81.0M - Series A - Dec 2020
View all 25 Funding Rounds on Tracxn Platform

17. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Sonoma Biothe.. (2012, United States)
$265M - Series B - Aug 2021
Ventyx Biosci.. (2018, United States)
$114M - Series B - Mar 2021
BioTheryX (2007, United States)
$92.1M - Series E - May 2021
Regor (2018, United States)
$90.0M - Series B - Feb 2021
ROME Therapeu.. (2020, United States)
$77.0M - Series B - Sep 2021
Interius Biot.. (2020, United States)
$76.0M - Series A - May 2021
PlateletBio (2019, United States)
$75.5M - Series B - Nov 2021
View all 26 Funding Rounds on Tracxn Platform
Autoimmune Disorders Drugs
09
17
Back to index
Immunology (Horizon Therapeutics)
(# Cos: 866 | $21.3B)
Drugs (Moderna)
(# Cos: 724 | $20.4B)
Autoimmune Diseases (Biogen)
(# Cos: 113 | $6.8B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.2B (▲46.6%)
26(▲30%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$6.8B
77
19
113
19
Biogen
(1978, United States, $80.0M)
Moderna
(2010, United States, $2.8B)
Horizon Therapeutics
(2008, Ireland, $61.8M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

18. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Sonoma Biothe.. (2012, United States)
$265M - Series B - Aug 2021
Amylyx Pharma.. (2013, United States)
$135M - Series C - Jul 2021
Skyhawk Thera.. (2017, United States)
$133M - Series B - Sep 2021
Shape Therape.. (2018, United States)
$112M - Series B - Jul 2021
LEXEO Therape.. (2018, United States)
$100M - Series B - Sep 2021
LEXEO Therape.. (2018, United States)
$85.0M - Series A - Jan 2021
Vanqua Bio (2019, United States)
$85.0M - Series B - Sep 2021
View all 37 Funding Rounds on Tracxn Platform
Neurodegenerative Disorders Drugs
10
18
Back to index
Neurology (MindMaze)
(# Cos: 2511 | $30.2B)
Drugs (AskBio)
(# Cos: 1341 | $23.7B)
Neurodegenerative (Biogen)
(# Cos: 488 | $8.4B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.1B (▲68%)
37(▲2.8%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
30
$8.4B
339
56
488
49
Biogen
(1978, United States, $80.0M)
AskBio
(2001, United States, $235M)
PTC Therapeutics
(1998, United States, $248M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

19. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
ElevateBio (2018, United States)
$525M - Series C - Mar 2021
Wugen (2018, United States)
$172M - Series B - Jul 2021
Monte Rosa Th.. (2020, United States)
$95.0M - Series C - Mar 2021
Heyuan Biotechnology (2018, China)
$64.2M - Series C - Oct 2021
Ossium Health (2016, United States)
$63.0M - Series B - Mar 2021
Ajax (2019, United States)
$40.0M - Series C - Jun 2021
MingSight (2009, United States)
$20.0M - Series A - Nov 2021
View all 13 Funding Rounds on Tracxn Platform
Hematologic Cancer Drugs
11
19
Back to index
Oncology (Guardant Health)
(# Cos: 4430 | $97.3B)
Drugs (Moderna)
(# Cos: 2837 | $74.5B)
Blood Cancer (Sierra Oncology)
(# Cos: 85 | $4.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.0B (▲75.1%)
13(▲62.5%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
8
$4.2B
67
21
85
10
Sierra Oncology
(2003, Canada, $75.0M)
ASLAN Pharmaceuticals
(2010, Singapore, $100M)
Kiadis Pharma
(1997, Netherlands, $33.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

20. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Hummingbird Biosc.. (2015, Singapore)
$125M - Series C - May 2021
Obsidian Ther.. (2015, United States)
$115M - Series B - Sep 2021
Boundless Bio (2018, United States)
$106M - Series B - Apr 2021
Elpiscience (2017, China)
$105M - Series C - May 2021
TScan Therape.. (1995, United States)
$100M - Series C - Jan 2021
Wuhan Binhui Biotechn.. (2010, China)
$94.9M - Series C - Feb 2021
DiCE Molecules (2013, United States)
$80.0M - Series C - Jan 2021
View all 29 Funding Rounds on Tracxn Platform
Pan-Cancer Drugs
12
20
Back to index
Oncology (Guardant Health)
(# Cos: 4430 | $97.3B)
Drugs (Moderna)
(# Cos: 2837 | $74.5B)
Pan Cancer (GigaGen)
(# Cos: 346 | $7.6B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$1.0B (▼48.5%)
29(▼42%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
25
$7.6B
226
45
346
41
GigaGen
(2011, United States, $36.1M)
Obsidian Therapeutics
(2015, United States, $165M)
TScan Therapeutics
(1995, United States, $180M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

21. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
NewAmsterdam Ph.. (2019,
Netherlands)
$196M - Series A - Jan 2021
CinCor (2018, United States)
$143M - Series B - Oct 2021
Tenaya Therap.. (2016, United States)
$106M - Series C - Mar 2021
TransThera Biosciences (2016, China)
$100M - Series D - Jul 2021
Cardior Pharmaceuti.. (2016, Germany)
$75.2M - Series B - Aug 2021
Juventas Ther.. (2007, United States)
$64.2M - Series C - Oct 2021
Ixaka (2009, United Kingdom)
$54.3M - Series C - Jan 2021
View all 20 Funding Rounds on Tracxn Platform
Diversified
13
21
Back to index
Cardiac and Vascular Disorders (Eko)
(# Cos: 2543 | $30.4B)
Drugs (Moderna)
(# Cos: 330 | $10.2B)
Diversified (Sarepta)
(# Cos: 257 | $5.8B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$890M (▲799%)
20(▲66.7%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
43
$5.8B
201
43
257
17
Sarepta
(1980, United States)
Tenaya Therapeutics
(2016, United States, $248M)
Esperion Therapeutics
(1998, United States, $130M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

22. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Somalogic (1999, United States)
$212M - Series E - Dec 2020
Nautilus Biot.. (2016, United States)
$200M - Series C - Jun 2021
Somalogic (1999, United States)
$121M - Series E - Nov 2020
Amunix (2006, United States)
$117M - Series B - Mar 2021
Frontier Medi.. (2018, United States)
$88.5M - Series B - Jul 2021
Amphista The.. (2018, United Kingdom)
$53.0M - Series B - Mar 2021
A-Alpha Bio (2017, United States)
$20.0M - Series A - Sep 2021
View all 13 Funding Rounds on Tracxn Platform
Proteomics Research Services
14
22
Back to index
Life Sciences Platforms and Tools (Illumina)
(# Cos: 9736 | $52.1B)
Research Services (Ginkgo Bioworks)
(# Cos: 5051 | $32.3B)
Proteomics (Atomwise)
(# Cos: 272 | $2.3B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$852M (▲175%)
13(▲8.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
20
$2.3B
98
3
272
15
Atomwise
(2012, United States, $175M)
Biognosys
(2008, Switzerland, $9.1M)
ProteinSimple
(2004, United States, $94.3M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

23. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
AboGen (2012, United States)
$700M - Series A - Aug 2021
Bridge to Life (2012, United States)
$56.0M - Series A - Aug 2021
Origincell (2014, China)
$30.9M - Series A - Jan 2021
Genepoint Biological .. (2015, China)
$18.8M - Series C - Jun 2021
PanTHERA CryoSolutions (2018, Canada)
$4.0M - Series A - Jan 2021
PanTHERA CryoSolutions (2018, Canada)
$2.0M - Seed - Dec 2020
Fluisense (2010, Denmark)
$216K - Seed - Nov 2020
View all 10 Funding Rounds on Tracxn Platform
Biopreservation Devices
15
23
Back to index
Life Sciences Platforms and Tools (Ginkgo Bioworks)
(# Cos: 9736 | $52.1B)
Instruments (Illumina)
(# Cos: 1991 | $11.4B)
Preservation (Brooks Automation)
(# Cos: 80 | $911M)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$812M (▲3320%)
10(▲233%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
6
$911M
38
1
80
2
Brooks Automation
(1978, United States)
Stirling Ultracold
(2009, United States, $8.7M)
Atelerix
(2017, United Kingdom, $1.5M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

24. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Inari (2016, United States)
$208M - Series D - May 2021
Benson Hill (2012, United States)
$159M - Series D - Dec 2020
Modern Meadow (2011, United States)
$130M - Series C - Apr 2021
Benson Hill (2012, United States)
$125M - Series D - Mar 2021
Pairwise (2017, United States)
$90.0M - Series B - Feb 2021
Equinom (2012, Israel)
$20.0M - Series C - Jun 2021
Biome Makers (2015, United States)
$15.0M - Series B - Aug 2021
View all 23 Funding Rounds on Tracxn Platform
Agrigenomics
16
24
Back to index
Genomics (MyHeritage)
(# Cos: 7580 | $80.5B)
Applied Genomics (23andMe)
(# Cos: 4093 | $53.3B)
Agrigenomics (Pioneer)
(# Cos: 296 | $4.4B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$807M (▲559%)
23(▲43.8%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
36
$4.4B
136
17
296
21
Pioneer
(1935, United States, $1.7B)
Limagrain
(1965, France, $200M)
Arcadia Biosciences
(2002, United States, $101M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

25. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Genomic Sequence Analysis Softwares
17
25
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$773M (▲71%)
16(▼33.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
51
$3.2B
192
9
510
21
Life Sciences Tech (Medidata)
(# Cos: 4693 | $24.4B)
Research & Development (Illumina)
(# Cos: 3792 | $20.5B)
Drug Discovery (ATAI)
(# Cos: 1141 | $11.6B)
Genomics (Personalis)
(# Cos: 707 | $5.1B)
Sequencing Analysis (Human Longevity)
(# Cos: 510 | $3.2B)
Human Longevity
(2013, United States, $330M)
Personalis
(2011, United States, $87.3M)
Qiagen
(1984, Germany)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Element Biosc.. (2017, United States)
$276M - Series C - Jun 2021
Deep Genomics (2015, Canada)
$180M - Series C - Jul 2021
Hexagon Bio (2017, United States)
$61.0M - Series B - Sep 2021
Immunitas The.. (2019, United States)
$58.0M - Series B - Aug 2021
CAMP4 (2018, United States)
$45.0M - Series B - Mar 2021
ChromaCode (2012, United States)
$38.6M - Series C - Dec 2020
Genomics (2014, United Kingdom)
$30.0M - Series B - Mar 2021
View all 16 Funding Rounds on Tracxn Platform

26. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Color (2013, United States)
$167M - Series D - Jan 2021
PathAI (2016, United States)
$165M - Series C - May 2021
Jiyinga Technology (2015, China)
$116M - Series C - Jul 2021
Personal Genome (2010, United States)
$103M - Series C - Feb 2021
Color (2013, United States)
$100M - Series E - Nov 2021
Earli (2018, United States)
$40.0M - Series A - Jan 2021
Craif (2018, Japan)
$11.3M - Series B - Nov 2021
View all 14 Funding Rounds on Tracxn Platform
Cancer Diagnostic Tests
18
26
Back to index
Oncology (Moderna)
(# Cos: 4430 | $97.3B)
In-Vitro Diagnostic Tests (Guardant Health)
(# Cos: 1135 | $18.0B)
Pan Cancer (GRAIL)
(# Cos: 197 | $5.7B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$737M (▼32.6%)
14(▼33.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
23
$5.7B
126
9
197
19
GRAIL
(2016, United States, $2.0B)
Color
(2013, United States, $491M)
PathAI
(2016, United States, $255M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

27. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Apollo Thera.. (2007, United Kingdom)
$145M - Series A - Jun 2021
Nimbus Therap.. (2009, United States)
$105M - Series D - Jul 2021
Evommune (2020, United States)
$83.0M - Series A - Sep 2021
Aristea Thera.. (2018, United States)
$63.0M - Series B - Jul 2021
Nereid (1999, United States)
$50.0M - Series A - Nov 2020
Sparrow Pharm.. (2013, United States)
$50.0M - Series A - May 2021
Resolution T.. (2017, United Kingdom)
$35.6M - Series A - Dec 2020
View all 19 Funding Rounds on Tracxn Platform
Inflammatory Diseases Drugs
19
27
Back to index
Immunology (Moderna)
(# Cos: 866 | $21.3B)
Drugs (Biogen)
(# Cos: 724 | $20.4B)
Inflammatory Diseases (Nimbus
Therapeutics)
(# Cos: 223 | $3.7B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$654M (▲10.8%)
19(▼17.4%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
21
$3.7B
161
22
223
25
Nimbus Therapeutics
(2009, United States, $242M)
Inotrem
(2013, France, $123M)
RedHill Biopharma
(2009, Israel, $13.5M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

28. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Diabetes Drugs
20
28
Back to index
Diabetes (Dexcom)
(# Cos: 898 | $9.1B)
Drugs (Pendulum)
(# Cos: 236 | $4.9B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$606M (▲13.9%)
21(▼4.5%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
19
$4.9B
163
24
236
25
Pendulum
(2012, United States, $57.0M)
Xeris Pharma
(2005, United States, $155M)
Ocugen
(2013, United States, $18.9M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Jaguar Gene T.. (2019, United States)
$139M - Series B - Apr 2021
ViaCyte (1999, United States)
$115M - Series D - Jun 2021
Kriya Therape.. (2012, United States)
$100M - Series B - Jul 2021
Gmax Biopharm (2010, China)
$78.0M - Series C - Mar 2021
ViaCyte (1999, United States)
$53.9M - Series D - Apr 2021
Elevian (2017, United States)
$40.0M - Series A - Sep 2021
Imcyse (2010, Belgium)
$25.8M - Series B - Feb 2021
View all 21 Funding Rounds on Tracxn Platform

29. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
At-Home Preventive Genetic Test Kits
21
29
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$598M (▲312%)
10(▲42.9%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
9
$1.3B
49
2
201
9
Genomics (Illumina)
(# Cos: 7580 | $80.5B)
Applied Genomics (MyHeritage)
(# Cos: 4093 | $53.3B)
Consumer Genomics (23andMe)
(# Cos: 820 | $3.5B)
Proactive Healthcare (Everly
Wellness)
(# Cos: 201 | $1.3B)
Everly Wellness
(2015, United States, $305M)
Color
(2013, United States, $491M)
Viome
(2016, United States, $125M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Everly Wellness (2015, United States)
$175M - Series D - Dec 2020
Color (2013, United States)
$167M - Series D - Jan 2021
Color (2013, United States)
$100M - Series E - Nov 2021
Everly Wellness (2015, United States)
$75.0M - Series D - Jan 2021
Viome (2016, United States)
$54.0M - Series B - Nov 2021
Recuro Health (2021, United States)
$15.0M - Series A - Aug 2021
Digbi Health (2018, United States)
$5.4M - Series A - Mar 2021
View all 10 Funding Rounds on Tracxn Platform

30. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Pivot Bio (2010, United States)
$430M - Series D - Jul 2021
Antheia (2013, United States)
$73.0M - Series B - Jul 2021
LifeMine Ther.. (2016, United States)
$50.0M - Series B - Jan 2021
OriCiro Genomics (2018, Japan)
$7.3M - Series B - Jul 2021
Jiaxing Xinbei Lai Bi.. (2017, China)
$1.5M - Seed - Sep 2021
CC Bio (2018, United Kingdom)
$1.2M - Seed - Aug 2021
General Biosystems (2014, China)
Undisclosed - Seed - May 2021
View all 10 Funding Rounds on Tracxn Platform
Synthetic Biology
22
30
Back to index
Genomics (MyHeritage)
(# Cos: 7580 | $80.5B)
Applied Genomics (23andMe)
(# Cos: 4093 | $53.3B)
Synthetic Biology (Ginkgo Bioworks)
(# Cos: 68 | $4.0B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$563M (▲105%)
10(▲11.1%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
8
$4.0B
53
4
68
12
Ginkgo Bioworks
(2009, United States, $796M)
Synlogic Therapeutics
(2013, United States, $34.4M)
Amyris
(2003, United States, $487M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

31. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
COVID-19 Drugs
23
31
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$562M (▲186%)
12(▲50%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$1.0B
40
7
72
8
Infectious Diseases (Oxford Immunotec)
(# Cos: 1961 | $26.4B)
Drugs (Vir Biotechnology)
(# Cos: 1055 | $21.5B)
Viral (Moderna)
(# Cos: 471 | $11.7B)
COVID-19 (GigaGen)
(# Cos: 72 | $1.0B)
GigaGen
(2011, United States, $36.1M)
Adagio
(2020, United States, $466M)
NantKwest
(2002, United States, $147M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Adagio (2020, United States)
$336M - Series C - Apr 2021
Nano (2003, United States)
$90.0M - Series C - Mar 2021
Touchlight (2008, United Kingdom)
$58.4M - Series B - Mar 2021
Vaxxinity (2019, United States)
$27.0M - Series B - Mar 2021
ExeVir Bio (2020, Belgium)
$22.7M - Series A - Mar 2021
PharmCADD (2019, South Korea)
$15.5M - Series B - Mar 2021
Ashvattha The.. (2019, United States)
$7.7M - Series A - Apr 2021
View all 12 Funding Rounds on Tracxn Platform

32. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
DNA Liquid Biopsy Diagnostics
24
32
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$553M (▼38.9%)
15(▲15.4%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
11
$4.5B
64
6
98
11
Genomics (MyHeritage)
(# Cos: 7580 | $80.5B)
Applied Genomics (23andMe)
(# Cos: 4093 | $53.3B)
Clinical Genomics (Hologic)
(# Cos: 2181 | $39.4B)
Diagnostics (Invitae)
(# Cos: 1624 | $26.5B)
Sequencing-based (Adaptive
Biotechnologies)
(# Cos: 1327 | $24.5B)
Liquid Biopsy (GRAIL)
(# Cos: 247 | $5.6B)
DNA (Guardant Health)
(# Cos: 98 | $4.5B)
Guardant Health
(2012, United States, $558M)
GRAIL
(2016, United States, $2.0B)
Inivata
(2014, United Kingdom, $164M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Jiyinga Technology (2015, China)
$116M - Series C - Jul 2021
Delfi Diagnos.. (2019, United States)
$101M - Series A - Jan 2021
C2i Genomics (2019, United States)
$100M - Series B - Apr 2021
Scipher Medic.. (2014, United States)
$82.0M - Series C - Mar 2021
Nucleix (2008, Israel)
$55.0M - Series C - Apr 2021
Inivata (2014, United Kingdom)
$35.0M - Series C - Feb 2021
Gene Solutions (2018, Vietnam)
$15.0M - Series B - Oct 2021
View all 15 Funding Rounds on Tracxn Platform

33. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Nucleic Acid Sequencing Equipment
25
33
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$544M (▼6.2%)
12(▼14.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
17
$3.2B
59
7
88
10
Life Sciences Platforms and Tools (Ginkgo Bioworks)
(# Cos: 9736 | $52.1B)
Instruments (10X Genomics)
(# Cos: 1991 | $11.4B)
Genomics (Nanopore)
(# Cos: 208 | $4.5B)
Nucleic Acid Sequencing (Illumina)
(# Cos: 88 | $3.2B)
Illumina
(1998, United States, $28.0M)
Nanopore
(2005, United Kingdom, $1.3B)
PacBio
(2004, United States, $342M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Nanopore (2005, United Kingdom)
$271M - Series H - May 2021
GenapSys (2010, United States)
$70.0M - Series D - Mar 2021
GeneMind (2012, China)
$63.6M - Series B - Sep 2021
Qi Carbon Technology (2016, China)
$62.5M - Series B - Jun 2021
GeneMind (2012, China)
$38.7M - Series B - Jun 2021
Jinshi Technology (2017, China)
$15.5M - Series B - Sep 2021
QuantuMDx (2008, United Kingdom)
$15.2M - Series C - Mar 2021
View all 12 Funding Rounds on Tracxn Platform

34. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Genomic Sequencing Instruments
26
34
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$507M (▲46.6%)
13( <> 0% )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
11
$2.4B
56
5
99
10
Genomics (23andMe)
(# Cos: 7580 | $80.5B)
Enabling Technologies (Twist Bioscience)
(# Cos: 1688 | $16.1B)
Instrument Systems (10X Genomics)
(# Cos: 326 | $5.1B)
Nucleic Acid Analysis (PacBio)
(# Cos: 198 | $3.1B)
Sequencing (Nanopore)
(# Cos: 99 | $2.4B)
Nanopore
(2005, United Kingdom, $1.3B)
PacBio
(2004, United States, $342M)
Purigen Biosystems
(2012, United States, $88.3M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Nanopore (2005, United Kingdom)
$271M - Series H - May 2021
GeneMind (2012, China)
$63.6M - Series B - Sep 2021
Qi Carbon Technology (2016, China)
$62.5M - Series B - Jun 2021
GeneMind (2012, China)
$38.7M - Series B - Jun 2021
Purigen Biosy.. (2012, United States)
$34.4M - Series C - Apr 2021
Jinshi Technology (2017, China)
$15.5M - Series B - Sep 2021
QuantuMDx (2008, United Kingdom)
$15.2M - Series C - Mar 2021
View all 13 Funding Rounds on Tracxn Platform

35. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Ophthalmology Drugs
27
35
Back to index
Ophthalmology (Zeiss)
(# Cos: 981 | $11.5B)
Drugs (CureVac)
(# Cos: 320 | $6.6B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$463M (▲228%)
33( <> 0% )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
36
$6.6B
225
44
320
42
CureVac
(2000, Germany, $975M)
Ocugen
(2013, United States, $18.9M)
Gyroscope
(2016, United Kingdom, $255M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Gyroscope (2016, United Kingdom)
$148M - Series C - Mar 2021
Vedere (2019, United States)
$77.0M - Series A - May 2021
INTERGALACTIC.. (2020, United States)
$75.0M - Series A - Oct 2021
Oxford BioMe.. (1995, United Kingdom)
$68.3M - Series C - Sep 2021
Wuhan Newfoss Biotech.. (2008, China)
$62.0M - Series B - Feb 2021
Oculis (2003, Switzerland)
$57.0M - Series C - May 2021
Atsena Therap.. (2020, United States)
$55.0M - Series A - Dec 2020
View all 33 Funding Rounds on Tracxn Platform

36. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Patient Recruitment Platforms for
Clinical Trials
28
36
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$462M (▲594%)
9(▼18.2%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
11
$864M
69
-
207
10
Life Sciences Tech (Veeva Systems)
(# Cos: 4693 | $24.4B)
Research & Development (Illumina)
(# Cos: 3792 | $20.5B)
Clinical Trials (Medidata)
(# Cos: 946 | $3.5B)
Scientific Sourcing (myTomorrows)
(# Cos: 243 | $995M)
Patients (TrialSpark)
(# Cos: 207 | $864M)
TrialSpark
(2014, United States, $156M)
myTomorrows
(2012, Netherlands, $22.3M)
PatientsLikeMe
(2004, United States, $151M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Reify Health (2012, United States)
$220M - Series C - Aug 2021
TrialSpark (2014, United States)
$156M - Series C - Oct 2021
PatientsLikeMe (2004, United States)
$26.0M - Series D - Feb 2021
Antidote (2008, United Kingdom)
$23.2M - Series C - Jun 2021
Mendel Health (2016, United States)
$18.0M - Series A - Jun 2021
HealthMatch (2016, Australia)
$13.4M - Series B - Dec 2020
BEKHealth (2016, United States)
$4.6M - Series A - Jun 2021
View all 9 Funding Rounds on Tracxn Platform

37. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
RNA Interference Platforms
29
37
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$448M (▼34.8%)
6(▲20%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
4
$2.0B
39
8
60
8
Genomics (23andMe)
(# Cos: 7580 | $80.5B)
Enabling Technologies (Nanopore)
(# Cos: 1688 | $16.1B)
Technology Platforms (Twist Bioscience)
(# Cos: 363 | $7.6B)
RNA interference (CureVac)
(# Cos: 60 | $2.0B)
CureVac
(2000, Germany, $975M)
Dicerna Pharmaceuticals
(2007, United States, $107M)
Expansion Therapeutics
(2016, United States, $140M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Siwei Biotechnology (2016, China)
$188M - Series B - Jun 2021
oRNA (2020, United States)
$80.0M - Series A - Feb 2021
Expansion The.. (2016, United States)
$80.0M - Series B - Sep 2021
Cardior Pharmaceuti.. (2016, Germany)
$75.2M - Series B - Aug 2021
Envisagenics (2013, United States)
$19.2M - Series A - Sep 2021
Gatehouse Bio (2016, United States)
$5.4M - Series A - Jan 2021

38. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Caribou Biosc.. (2011, United States)
$115M - Series C - Mar 2021
Alchemab (2019, United Kingdom)
$82.7M - Series A - Apr 2021
Bluepha (2014, China)
$61.7M - Series B - Aug 2021
Lifebit (2017, United Kingdom)
$60.0M - Series B - Sep 2021
Clear Labs (2014, United States)
$60.0M - Series C - May 2021
Health Gene Technolog.. (2011, China)
$33.4M - Series A - Dec 2020
Equinom (2012, Israel)
$20.0M - Series C - Jun 2021
View all 36 Funding Rounds on Tracxn Platform
Genomics Research Services
30
38
Back to index
Life Sciences Platforms and Tools (Illumina)
(# Cos: 9736 | $52.1B)
Research Services (Ginkgo Bioworks)
(# Cos: 5051 | $32.3B)
Genomics (Personalis)
(# Cos: 827 | $2.5B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$444M (▲77.5%)
36(▲28.6%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
57
$2.5B
241
20
827
28
Personalis
(2011, United States, $87.3M)
Ancestry
(1996, United States, $146M)
Caribou Biosciences
(2011, United States, $157M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

39. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Vedere (2019, United States)
$77.0M - Series A - May 2021
Wuhan Newfoss Biotech.. (2008, China)
$62.0M - Series B - Feb 2021
Atsena Therap.. (2020, United States)
$55.0M - Series A - Dec 2020
LENZ Therapeu.. (2021, United States)
$47.0M - Series A - Jun 2021
Sydnexis (2014, United States)
$45.0M - Series B - Aug 2021
Phanes Therap.. (2016, United States)
$40.0M - Series B - May 2021
Visus Therape.. (2019, United States)
$36.0M - Series A - Mar 2021
View all 16 Funding Rounds on Tracxn Platform
Retinal Disorders Drugs
31
39
Back to index
Ophthalmology (Zeiss)
(# Cos: 981 | $11.5B)
Drugs (Ocugen)
(# Cos: 320 | $6.6B)
Retinal Disorders (CureVac)
(# Cos: 61 | $1.8B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$439M (▼44.2%)
16(▲6.7%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$1.8B
39
7
61
10
CureVac
(2000, Germany, $975M)
Rezolute
(2012, United States)
Visus Therapeutics
(2019, United States, $56.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

40. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Decentralized Clinical Trial Management
32
40
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$418M (▲215%)
4(▲33.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
-
$560M
4
-
7
3
Life Sciences Tech (Veeva Systems)
(# Cos: 4693 | $24.4B)
Research & Development (Illumina)
(# Cos: 3792 | $20.5B)
Clinical Trials (Medidata)
(# Cos: 946 | $3.5B)
Study Implementation (Unlearn)
(# Cos: 491 | $1.9B)
CTMS and EDC (Florence)
(# Cos: 454 | $1.4B)
CTMS (Clinical Ink)
(# Cos: 278 | $1.0B)
Decentralized Clinical Trials
(Medable)
(# Cos: 7 | $560M)
Medable
(2012, United States, $521M)
Curebase
(2017, United States, $19.0M)
Hawthorne Effect
(2015, United States, $20.1M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Medable (2012, United States)
$304M - Series D - Oct 2021
Medable (2012, United States)
$78.0M - Series C - Apr 2021
Hawthorne Eff.. (2015, United States)
$20.0M - Series A - Jun 2021
Curebase (2017, United States)
$16.4M - Series A - May 2021

41. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Genomics Based Drug Development
Software
33
41
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$404M (▲46.5%)
8(▲14.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
3
$1.5B
41
2
101
9
Life Sciences Tech (Medidata)
(# Cos: 4693 | $24.4B)
Research & Development (Illumina)
(# Cos: 3792 | $20.5B)
Drug Discovery (ATAI)
(# Cos: 1141 | $11.6B)
Genomics (Human Longevity)
(# Cos: 707 | $5.1B)
Drug Development (Insilico)
(# Cos: 101 | $1.5B)
Insilico
(2014, China, $310M)
Arrakis Therapeutics
(2015, United States, $113M)
Brightseed
(2018, United States, $52.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Insilico (2014, China)
$255M - Series C - Jun 2021
Expansion The.. (2016, United States)
$80.0M - Series B - Sep 2021
Lifebit (2017, United Kingdom)
$60.0M - Series B - Sep 2021
Kinomica (2017, United Kingdom)
$5.2M - Series A - Dec 2020
PhenoTips (2012, Canada)
$2.0M - Seed - Sep 2021
Mass Dynamics (2015, Australia)
$1.5M - Seed - May 2021
Xbiome (2019, China)
Undisclosed - Series B - Dec 2020
View all 8 Funding Rounds on Tracxn Platform

42. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Metabolic Disorders Drugs
34
42
Back to index
Metabolic Diseases (MannKind Corp)
(# Cos: 403 | $10.5B)
Drugs (Millendo Therapeutics)
(# Cos: 273 | $8.8B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$389M (▲128%)
28(▼17.6%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
32
$8.8B
220
61
273
37
Millendo Therapeutics
(2012, United States, $128M)
MannKind Corp
(1991, United States, $50.0M)
Sigilon
(2015, United States, $195M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
VISEN Pharmaceuticals (2018, China)
$150M - Series B - Jan 2021
Jaguar Gene T.. (2019, United States)
$139M - Series B - Apr 2021
ViaCyte (1999, United States)
$115M - Series D - Jun 2021
Shape Therape.. (2018, United States)
$112M - Series B - Jul 2021
Nimbus Therap.. (2009, United States)
$105M - Series D - Jul 2021
Regor (2018, United States)
$90.0M - Series B - Feb 2021
Gmax Biopharm (2010, China)
$78.0M - Series C - Mar 2021
View all 28 Funding Rounds on Tracxn Platform

43. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Esco (1978, United States)
$200M - Series A - May 2021
Truvian (2015, United States)
$105M - Series C - Feb 2021
Sphere Fluid.. (2010, United Kingdom)
$40.0M - Series C - Oct 2021
Mozhuo Biotechnology (2016, China)
$23.1M - Series A - Aug 2021
Baicare (2016, China)
Undisclosed - Series C - Oct 2021
ThunderBio Innovation (2018, China)
Undisclosed - Seed - Aug 2021
ThunderBio Innovation (2018, China)
Undisclosed - Series A - Aug 2021
View all 9 Funding Rounds on Tracxn Platform
Life Sciences Research Instruments
35
43
Back to index
Life Sciences Platforms and Tools (Ginkgo Bioworks)
(# Cos: 9736 | $52.1B)
Instruments (Illumina)
(# Cos: 1991 | $11.4B)
Diversified (10X Genomics)
(# Cos: 372 | $843M)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$368M (▲1191%)
9(▲350%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
42
$843M
84
15
372
4
10X Genomics
(2012, United States, $274M)
Beckman Coulter
(1935, United States)
Bruker
(1960, United States)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

44. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Affinivax (2013, United States)
$226M - Series C - Jan 2021
MicuRx Pharma.. (2007, United States)
$107M - Series E - Dec 2020
Vedanta Biosc.. (2010, United States)
$68.0M - Series D - Jul 2021
Minervax (2010, Denmark)
$57.4M - Series B - Dec 2020
Adaptive Phag.. (2016, United States)
$40.8M - Series B - May 2021
Micreos (2005, Netherlands)
$37.3M - Series D - Sep 2021
SpyBiotech (2017, United Kingdom)
$32.5M - Series A - Feb 2021
View all 20 Funding Rounds on Tracxn Platform
Anti Bacterial Drugs
36
44
Back to index
Infectious Diseases (Oxford Immunotec)
(# Cos: 1961 | $26.4B)
Drugs (Moderna)
(# Cos: 1055 | $21.5B)
Bacterial (Locus Biosciences)
(# Cos: 331 | $5.1B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$360M (▲107%)
20(▼23.1%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
36
$5.1B
239
37
331
32
Locus Biosciences
(2015, United States, $32.3M)
Bioversys
(2008, Switzerland, $28.4M)
Vedanta Biosciences
(2010, United States, $232M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

45. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Molecular Modeling Solutions
37
45
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$358M (▲ >10K%)
8(▲100%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
2
$443M
45
-
109
4
Life Sciences Tech (Medidata)
(# Cos: 4693 | $24.4B)
Research & Development (Illumina)
(# Cos: 3792 | $20.5B)
Drug Informatics (Benchling)
(# Cos: 746 | $3.3B)
Molecular Modeling (Asimov)
(# Cos: 109 | $443M)
Asimov
(2017, United States, $4.7M)
Cellarity
(2015, United States, $173M)
PharmEnable
(2016, United Kingdom, $2.2M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Cellarity (2015, United States)
$123M - Series B - Feb 2021
Stonewise (2018, China)
$100M - Series B - Apr 2021
Entos (2019, United States)
$53.0M - Series A - Jul 2021
Enveda (2019, United States)
$51.0M - Series A - Jun 2021
Reverie Labs (2017, United States)
$25.0M - Series A - Feb 2021
Enveda (2019, United States)
$4.9M - Seed - Dec 2020
Beijing Chaowei Zhiya.. (2020, China)
$1.5M - Seed - Jul 2021
View all 8 Funding Rounds on Tracxn Platform

46. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Artiva (2018, United States)
$120M - Series B - Feb 2021
Caribou Biosc.. (2011, United States)
$115M - Series C - Mar 2021
Trucode Gene .. (2016, United States)
$80.0M - Series C - Jan 2021
Health Gene Technolog.. (2011, China)
$33.4M - Series A - Dec 2020
mRNA (2016, United States)
$10.0M - Seed - Apr 2021
Genome Engineering Services
38
46
Back to index
Genomics (23andMe)
(# Cos: 7580 | $80.5B)
Genomics Services (Personalis)
(# Cos: 847 | $2.2B)
Genome Engineering (Caribou
Biosciences)
(# Cos: 95 | $542M)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$358M (▲346%)
5(▲66.7%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
5
$542M
26
1
95
5
Caribou Biosciences
(2011, United States, $157M)
Artiva
(2018, United States, $198M)
Canopy Biosciences
(2016, United States, $4.5M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

47. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Jaguar Gene T.. (2019, United States)
$139M - Series B - Apr 2021
Regor (2018, United States)
$90.0M - Series B - Feb 2021
Atavistik (2021, United States)
$60.0M - Series A - Aug 2021
Rivus Pharmac.. (2019, United States)
$35.0M - Series A - Jun 2021
Stemson Thera.. (2019, United States)
$15.0M - Series A - Jul 2021
RosVivo Thera.. (2021, United States)
$5.5M - Series A - May 2021
Gila Therapeu.. (2014, United States)
$402K - Series A - Feb 2021
View all 8 Funding Rounds on Tracxn Platform
Metabolic Disorders Drugs
39
47
Back to index
Metabolic Diseases (MannKind Corp)
(# Cos: 403 | $10.5B)
Drugs (Millendo Therapeutics)
(# Cos: 273 | $8.8B)
Diversified (Inversago Pharma)
(# Cos: 26 | $440M)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$345M (▲1288%)
8(▲167%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
1
$440M
19
2
26
6
Inversago Pharma
(2015, Canada, $51.8M)
Aria Pharmaceuticals
(2015, United States, $14.3M)
Rivus Pharmaceuticals
(2019, United States, $35.0M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

48. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
HilleVax (2021, United States)
$135M - Series D - Sep 2021
Icosavax (2017, United States)
$100M - Series B - Apr 2021
Pulmocide (2013, United Kingdom)
$92.0M - Series C - May 2021
Pulmotect (2007, United States)
$3.5M - Series A - Mar 2021
Pneumagen (2016, United Kingdom)
$3.4M - Series A - Jan 2021
Peroxitech (2017, United States)
Undisclosed - Seed - May 2021
Lung Infection Drugs
40
48
Back to index
Pulmonology (Aerogen)
(# Cos: 648 | $7.9B)
Drugs (ASLAN Pharmaceuticals)
(# Cos: 189 | $4.8B)
Lung Infections (Icosavax)
(# Cos: 20 | $616M)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$334M (▲289%)
6(▲20%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
1
$616M
14
2
20
4
Icosavax
(2017, United States, $152M)
ReViral
(2011, United Kingdom, $121M)
Pulmocide
(2013, United Kingdom, $150M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

49. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Nanoparticle Based Drug Delivery
Systems
41
49
Back to index
Drug Delivery (Impel NeuroPharma)
(# Cos: 728 | $7.1B)
Nanoparticle Based (Acorda)
(# Cos: 223 | $1.2B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$330M (▲389%)
12(▲9.1%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
4
$1.2B
121
16
223
8
Acorda
(1995, United States, $66.5M)
Genedit
(2016, United States, $34.5M)
Liquidia
(2004, United States, $90.3M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Siwei Biotechnology (2016, China)
$188M - Series B - Jun 2021
Elucida Oncol.. (2014, United States)
$44.0M - Series B - Jan 2021
Genedit (2016, United States)
$26.0M - Series A - Sep 2021
Bionaut Labs (2015, United States)
$20.0M - Series B - Mar 2021
Sisaf (2006, United Kingdom)
$13.2M - Series B - Nov 2020
Clene Nanomed.. (2012, United States)
$9.3M - Series D - May 2021
NanoSyrinx (2018, United Kingdom)
$8.5M - Seed - Jul 2021
View all 12 Funding Rounds on Tracxn Platform

50. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Cancer Precision Medicine Diagnostic
Tests
42
50
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$327M (▲585%)
12(▲50%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
3
$652M
32
2
52
8
Oncology (Moderna)
(# Cos: 4430 | $97.3B)
In-Vitro Diagnostic Tests (Adaptive
Biotechnologies)
(# Cos: 1135 | $18.0B)
Diversified (Guardant Health)
(# Cos: 499 | $9.0B)
Precision Medicine (Personalis)
(# Cos: 52 | $652M)
Personalis
(2011, United States, $87.3M)
HalioDx
(2015, France, $31.3M)
OncoDNA
(2012, Belgium, $37.4M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
ITM (2004, Germany)
$109M - Series D - Apr 2021
Strata Oncology (2015, United States)
$90.0M - Series C - Jul 2021
Xilis (2019, United States)
$70.0M - Series A - Jul 2021
ITM (2004, Germany)
$30.5M - Series D - Jun 2021
GloriousMed (2015, China)
$15.6M - Series B - Oct 2021
Known Medicine (2020, United States)
$7.2M - Seed - Aug 2021
Swiss Nuclides (2017, Switzerland)
$2.8M - Seed - Jun 2021
View all 12 Funding Rounds on Tracxn Platform

51. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Eliem Therape.. (2018, United States)
$80.0M - Series C - Mar 2021
Eliem Therape.. (2018, United States)
$60.0M - Series C - May 2021
Allay Therape.. (2017, United States)
$60.0M - Series C - Sep 2021
Novaremed (2008, Israel)
$50.0M - Series B - Jan 2021
1910 Genetics (2018, United States)
$25.7M - Series A - Mar 2021
Allay Therape.. (2017, United States)
$15.0M - Series B - Jul 2021
AlgoTx (2018, France)
$14.3M - Series A - Nov 2020
View all 13 Funding Rounds on Tracxn Platform
Neurological Pain Management Drugs
43
51
Back to index
Neurology (MindMaze)
(# Cos: 2511 | $30.2B)
Drugs (Biogen)
(# Cos: 1341 | $23.7B)
Pain (Zogenix)
(# Cos: 231 | $3.8B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$321M (▲238%)
13( <> 0% )
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
33
$3.8B
157
40
231
11
Zogenix
(2006, United States, $203M)
Flexion Therapeutics
(2007, United States, $62.0M)
AcelRx
(2005, United States, $22.8M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.

52. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Congestive Heart Failure Treatment
Devices
44
52
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$310M (▼6.5%)
15(▼6.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
16
$2.4B
89
7
106
21
Cardiac and Vascular Disorders (Moderna)
(# Cos: 2543 | $30.4B)
Medical Devices (Eko)
(# Cos: 2052 | $19.3B)
Therapeutic Devices (Inari Medical)
(# Cos: 996 | $14.5B)
Congestive Heart Failure
(Abiomed)
(# Cos: 106 | $2.4B)
Abiomed
(1981, United States)
Sequena Medical
(2006, Switzerland, $35.5M)
CardioKinetix
(2003, United States, $137M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Ancora Heart (2001, United States)
$80.0M - Series D - Jul 2021
Impulse Dynamics (1996, Germany)
$60.0M - Series D - Jan 2021
CorWave (2011, France)
$43.0M - Series C - Jan 2021
AdjuCor (2008, Germany)
$35.1M - Series B - Jun 2021
CoRISMA (2018, United States)
$27.0M - Series A - Aug 2021
Bivacor (2008, United States)
$19.0M - Series B - May 2021
FineHeart (2010, France)
$18.3M - Series B - Jun 2021
View all 15 Funding Rounds on Tracxn Platform

53. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Drug Resistant Infections
45
53
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$301M (▼19.7%)
12(▼33.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
22
$3.6B
156
23
209
21
Infectious Diseases (Oxford Immunotec)
(# Cos: 1961 | $26.4B)
Drugs (Moderna)
(# Cos: 1055 | $21.5B)
Bacterial (Bioversys)
(# Cos: 331 | $5.1B)
Drug Resistant Infections (Locus
Biosciences)
(# Cos: 209 | $3.6B)
Locus Biosciences
(2015, United States, $32.3M)
Bioversys
(2008, Switzerland, $28.4M)
Vedanta Biosciences
(2010, United States, $232M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
MicuRx Pharma.. (2007, United States)
$107M - Series E - Dec 2020
Vedanta Biosc.. (2010, United States)
$68.0M - Series D - Jul 2021
Adaptive Phag.. (2016, United States)
$40.8M - Series B - May 2021
Micreos (2005, Netherlands)
$37.3M - Series D - Sep 2021
Vedanta Biosc.. (2010, United States)
$25.0M - Series D - Jan 2021
Phico Therap.. (2000, United Kingdom)
$9.9M - Series A - May 2021
Resilient Bio.. (2016, United States)
$7.2M - Series A - Dec 2020
View all 12 Funding Rounds on Tracxn Platform

54. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Clinical Data Analysis Platforms
46
54
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$284M (▲931%)
10(▼9.1%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
10
$1.4B
87
5
259
9
Life Sciences Tech (Medidata)
(# Cos: 4693 | $24.4B)
Research & Development (Illumina)
(# Cos: 3792 | $20.5B)
Drug Informatics (Benchling)
(# Cos: 746 | $3.3B)
Clinical Data Analysis (Strand Life
Sciences)
(# Cos: 259 | $1.4B)
Strand Life Sciences
(2000, India, $34.9M)
NantHealth
(2007, United States, $608M)
Holmusk
(2015, Singapore, $34.3M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
iCarbonX (2015, China)
$151M - Series D - Apr 2021
BioAge Labs (2015, United States)
$90.0M - Series C - Dec 2020
Immuneering C.. (2008, United States)
$62.0M - Series B - Jan 2021
NeoCura (2019, United States)
$38.2M - Series A - Dec 2020
Elucidata (2015, United States)
$5.0M - Seed - Dec 2020
My Intelligent Machi.. (2016, Canada)
$5.0M - Seed - Apr 2021
baseimmune (2019, United Kingdom)
$4.8M - Seed - Nov 2021
View all 10 Funding Rounds on Tracxn Platform

55. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Wound Healing Drugs
47
55
Back to index
Wound Care (Imbed Biosciences)
(# Cos: 536 | $1.9B)
Drugs (Ilya Pharma)
(# Cos: 190 | $1.1B)
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$280M (▲493%)
11(▲22.2%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
19
$1.1B
127
22
190
11
Ilya Pharma
(2016, Sweden, $4.0M)
Kane Biotech
(2001, Canada, $42.5K)
CUTISS
(2017, Switzerland, $30.9M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
QBiotics (2000, Australia)
$64.4M - Series C - Jun 2021
Endeavor Biom.. (2018, United States)
$62.0M - Series A - Jan 2021
CytoKi Pharma (2019, Denmark)
$45.0M - Series A - May 2021
Resolution T.. (2017, United Kingdom)
$35.6M - Series A - Dec 2020
FirstString R.. (2006, United States)
$26.7M - Series B - Jun 2021
Medical Ethics (2004, Australia)
$24.9M - Series B - Feb 2021
Stemson Thera.. (2019, United States)
$15.0M - Series A - Jul 2021
View all 11 Funding Rounds on Tracxn Platform

56. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Genetic Engineering Technologies
48
56
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$280M (▲311%)
6(▼33.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
3
$1.2B
43
4
67
7
Genomics (23andMe)
(# Cos: 7580 | $80.5B)
Enabling Technologies (Nanopore)
(# Cos: 1688 | $16.1B)
Technology Platforms (eGenesis)
(# Cos: 363 | $7.6B)
Genetic Engineering (Twist
Bioscience)
(# Cos: 67 | $1.2B)
Twist Bioscience
(2013, United States, $334M)
Senti Biosciences
(2016, United States, $158M)
Tmunity Therapeutics
(2015, United States, $231M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Senti Bioscie.. (2016, United States)
$105M - Series B - Jan 2021
Bota (2019, United States)
$100M - Series B - Jul 2021
ADARx Pharmac.. (2019, United States)
$75.0M - Series B - Aug 2021
GeneScience Pharmaceu.. (1996, China)
Undisclosed - Series B - Mar 2021
GeneScience Pharmaceu.. (1996, China)
Undisclosed - Series A - Mar 2021
Bota (2019, United States)
Undisclosed - Seed - Mar 2021

57. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Cardiac Diagnostic Devices
49
57
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$274M (▲52.1%)
12(▼42.9%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
17
$1.5B
129
12
293
18
Cardiac and Vascular Disorders (Moderna)
(# Cos: 2543 | $30.4B)
Medical Devices (Inari Medical)
(# Cos: 2052 | $19.3B)
Screening Devices (Acutus Medical)
(# Cos: 410 | $2.8B)
Cardiac Diagnostic (Eko)
(# Cos: 293 | $1.5B)
Eko
(2013, United States, $95.0M)
AliveCor
(2011, United States, $114M)
Qardio
(2012, United States, $28.8M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Imperative Care (2015, United States)
$260M - Series D - Jul 2021
Ultromics (2017, United Kingdom)
$33.0M - Series B - Aug 2021
Bertis (2014, South Korea)
$13.5M - Series B - Jun 2021
Ai Highway (2018, India)
$124K - Seed - Mar 2021
LifeLens (2014, United States)
$78.2K - Series A - Oct 2021
Genetesis (2013, United States)
$75.0K - Series B - Oct 2021
Sunfox (2016, India)
$34.5K - Angel - Jun 2021
View all 12 Funding Rounds on Tracxn Platform

58. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Recent Funding Rounds
Gene Delivery Platforms
50
58
Back to index
Taxonomy
$ Invested in last 1 year
Key Stats
# Funding Rounds in last 1 year
$269M (▼4.8%)
11(▼8.3%)
Funded Companies
Companies
Acquisitions
Total $ Invested
IPOs
Soonicorn Club
14
$2.0B
79
7
114
10
Genomics (23andMe)
(# Cos: 7580 | $80.5B)
Enabling Technologies (Nanopore)
(# Cos: 1688 | $16.1B)
Technology Platforms (Twist Bioscience)
(# Cos: 363 | $7.6B)
Gene Delivery (Synthego)
(# Cos: 114 | $2.0B)
Synthego
(2012, United States, $260M)
American Gene
(2008, United States, $2.8M)
Genedit
(2016, United States, $34.5M)
Note: The last node in the Taxonomy represents the Business Model addressed in the title of the slide.
Cambridge Ep.. (2012, United Kingdom)
$88.0M - Series D - Nov 2021
StrideBio (2015, United States)
$81.5M - Series B - Mar 2021
Genedit (2016, United States)
$26.0M - Series A - Sep 2021
Mekonos (2016, United States)
$25.0M - Series A - Nov 2021
iVexSol (2018, Canada)
$13.0M - Series A - Dec 2020
Chameleon Bio.. (2017, United States)
$11.1M - Seed - Mar 2021
Bendao Gene Technology (2018, China)
$9.2M - Series A - Apr 2021
View all 11 Funding Rounds on Tracxn Platform

59. Life Sciences - Top Business Models Report Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Recent funding rounds
Investment Trends
Most Active Investors
Top Funded Business Models
Explore more on Tracxn
All Tech Companies
US Tech Companies
Online Travel Companies
Companies using AI in Healthcare
Companies founded by Stanford GSB Alumni
Soonicorn club in Fintech
Analyst Picks in Israel Tech
Key News in FinTech
Events in Bay Area
Angel Investors in United States
Bluebox
Companies Investment Activity
Miscellaneous
Company Detail Page of DoorDash
Competitors of Freshworks
Cap Table for TransferWise
Financials for Ola
Employee Count for Revolut
Company Due Diligence Exits
Public Companies
Acquired Companies
Most Active Acquirers
Reports
Delhivery - Company Report
Novel Foods - Business Model Report
HRTech - Feed Report
FinTech - Top Business Models Report
US Tech - Top Business Models Report
US Tech - Monthly Report
59

60. Life Sciences - Top Business Models Report Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Explore other Reports on Tracxn
HRTech
InsurTech
Food Tech
Novel Foods
Blockchain Network
P2P Remittance
Business Model Reports
FinTech Europe
Consumer Digital SEA
HiTech US
Feed Geo Reports
Company Reports
Monthly Unicorn Report
Unicorn Reports
Transferwise
Coursera
BigBasket
Feed Reports Top Business Models in PA
FinTech
Enterprise Applications
Artificial Intelligence
Geo Monthly Reports
US Tech
Europe Tech
China Tech
Top Business Models in Geo
India Tech
Israel Tech
UK & Ireland Tech
60

61. Copyright © 2021, Tracxn Technologies Limited. All rights reserved.
Life Sciences - Top Business Models Report
Thank You
61
Any and all information either accessed from the website www.tracxn.com or having otherwise originated from Tracxn Technologies Limited including but not limited to the information
contained herein ("Data") is the sole property of Tracxn Technologies Limited (hereinafter "Tracxn"). You shall not recirculate, distribute, transmit, publish, or sell the Data or any portion
thereof in any form or by any means, either for commercial or non-commercial use, or permit any third party to use or distribute the Data or any portion thereof; to any other party, except
with the prior written consent of Tracxn. You may however incorporate insubstantial portions, extracts, abstracts or summaries from the Data into analysis, presentations or tools for your
customers or for your internal use, so long as Tracxn is clearly and visibly identified as the source of information.
For further information please refer to our Terms of Use at www.tracxn.com